3DAJ

Crystal structure of Aurora A complexed with an inhibitor discovered through site-directed dynamic tethering


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 
    0.284 (Depositor) 
  • R-Value Work: 
    0.251 (Depositor), 0.250 (DCC) 
  • R-Value Observed: 
    0.253 (Depositor) 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history


Literature

Discovery of an Aurora kinase inhibitor through site-specific dynamic combinatorial chemistry.

Cancilla, M.T.He, M.M.Viswanathan, N.Simmons, R.L.Taylor, M.Fung, A.D.Cao, K.Erlanson, D.A.

(2008) Bioorg Med Chem Lett 18: 3978-3981

  • DOI: https://doi.org/10.1016/j.bmcl.2008.06.011
  • Primary Citation of Related Structures:  
    3DAJ

  • PubMed Abstract: 

    We demonstrate a fragment-based lead discovery method that combines site-directed ligand discovery with dynamic combinatorial chemistry. Our technique targets dynamic combinatorial screening to a specified region of a protein by using reversible disulfide chemistry. We have used this technology to rapidly identify inhibitors of the drug target Aurora A that span the purine-binding site and the adaptive pocket of the kinase. The binding mode of a noncovalent inhibitor has been further characterized through crystallography.


  • Organizational Affiliation

    Sunesis Pharmaceuticals, Inc., 395 Oyster Point Boulevard, Suite 400, South San Francisco, CA 94080, USA.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
serine/threonine kinase 6272Mus musculusMutation(s): 4 
Gene Names: AurkaStk6
EC: 2.7.11.1
UniProt & NIH Common Fund Data Resources
Find proteins for P97477 (Mus musculus)
Explore P97477 
Go to UniProtKB:  P97477
IMPC:  MGI:894678
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP97477
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
FXG
Query on FXG

Download Ideal Coordinates CCD File 
B [auth A]N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide
C22 H29 N7 O2
WOYITRCGMUXUDE-UHFFFAOYSA-N
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free:  0.284 (Depositor) 
  • R-Value Work:  0.251 (Depositor), 0.250 (DCC) 
  • R-Value Observed: 0.253 (Depositor) 
Space Group: P 41 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 84.932α = 90
b = 84.932β = 90
c = 77.025γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
MAR345dtbdata collection
MOSFLMdata reduction
SCALAdata scaling
AMoREphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

  • Released Date: 2008-07-08 
  • Deposition Author(s): He, M.M.

Revision History  (Full details and data files)

  • Version 1.0: 2008-07-08
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance
  • Version 1.2: 2021-10-20
    Changes: Database references, Derived calculations
  • Version 1.3: 2024-02-21
    Changes: Data collection